New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 11, 2014
04:55 EDTSTAA, STAA, STAA, VTL, VTL, VTL, ANAC, ANAC, ANAC, PTCT, PTCT, PTCT, SGMO, SGMO, SGMO, RNA, RNA, RNA, BLUE, BLUE, BLUE, BIND, BIND, BIND, FCSC, FCSC, FCSC, CRDC, CRDC, CRDC, DRTX, DRTX, DRTXWedbush to hold a conference
Life Sciences Management Conference to be held in New York on August 12-13.
News For DRTX;CRDC;FCSC;BIND;BLUE;RNA;SGMO;PTCT;ANAC;VTL;STAA From The Last 14 Days
Check below for free stories on DRTX;CRDC;FCSC;BIND;BLUE;RNA;SGMO;PTCT;ANAC;VTL;STAA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 29, 2014
07:24 EDTSTAAStephens to hold an investor trip
Subscribe for More Information
September 26, 2014
08:03 EDTRNAProsensa extends re-dosing of drisapersen in Europe
Subscribe for More Information
07:32 EDTFCSCBioCentury to hold a conference
21st Annual NewsMakers in the Biotech Industry Conference to be held in New York on September 26.
September 24, 2014
08:06 EDTFCSCFibrocell, Intrexon advance GM-HDF-COL7 toward IND application
Subscribe for More Information
08:06 EDTRNAProsensa publishes results of research into dystrophin in patients with DMD, BMD
Prosensa Holding announced that the results of its research into developing an accurate and reproducible method for the measurement of dystrophin in patients with Duchenne muscular dystrophy, or DMD, and Becker's muscular dystrophy, or BMD, have been published in the online peer reviewed journal PLOS ONE. This method has also been tested as part of an international consortium initiative, the Biochemical Outcome Measures study group, which focuses on the optimization of dystrophin assays.
08:06 EDTRNAProsensa publishes results of research into dystrophin in patients with DMD, BMD
Subscribe for More Information
07:17 EDTPTCTPTC Therapeutics price tarrget raised to $55 from $40 at Credit Suisse
Subscribe for More Information
07:03 EDTRNAProsensa initiated with a Neutral at Credit Suisse
Target $9.
September 23, 2014
10:02 EDTSGMO, BLUEOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:16 EDTBLUEbluebird bio initiated with a Buy at Roth Capital
Target $50.
08:54 EDTPTCTPTC Therapeutics price target raised to $50 from $37 at BofA/Merrill
Subscribe for More Information
06:03 EDTSGMOSangamo initiated with a Buy at Jefferies
Subscribe for More Information
September 22, 2014
16:07 EDTANACAnacor announces commercial launch of KERYDIN topical solution in U.S.
Subscribe for More Information
10:35 EDTPTCTPTC Therapeutics management to meet with Roth Capital
Subscribe for More Information
06:15 EDTVTLVital Therapies files to sell $46M in common stock
BofA/Merrill is acting as lead book running manager for the offering.
September 18, 2014
08:25 EDTRNAProsensa weakness creates buying opportunity, says Oppenheimer
Subscribe for More Information
September 17, 2014
14:57 EDTRNAProsensa announces commencement of re-dosing of drisapersen
Subscribe for More Information
14:56 EDTRNAProsensa commences re-dosing of drisapersen in North America DMD patients
12:32 EDTANACAnacor management to meet with Jefferies
Subscribe for More Information
08:04 EDTPTCTPTC Therapeutics prepares launch of Translarna in Europe
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use